{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:08:26Z","timestamp":1786990106885,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009544","name":"Society for Community Research and Action","doi-asserted-by":"publisher","award":["NKB-0200\/UN2"],"award-info":[{"award-number":["NKB-0200\/UN2"]}],"id":[{"id":"10.13039\/100009544","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.heliyon.2022.e09030","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T19:49:24Z","timestamp":1646164164000},"page":"e09030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Study of valproic acid liposomes for delivery into the brain through an intranasal route"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6775-4139","authenticated-orcid":false,"given":"Alhara","family":"Yuwanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Surini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahdiana","family":"Harahap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Jufri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2022.e09030_bib1","series-title":"J\u00a0Control Release","author":"Kapoor","year":"2016"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e09030_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/jps.23761","article-title":"Trends in translational medicine and drug targeting and delivery: new insights on an old concept - targeted drug delivery with antibody-drug conjugates for cancers","volume":"103","author":"Ho","year":"2014","journal-title":"J.\u00a0Pharmaceut. Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e09030_bib3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pharmthera.2012.03.003","article-title":"Pharmacology & Therapeutics Intranasal drug delivery : an ef fi cient and non-invasive route for systemic administration Focus on opioids","volume":"134","author":"Grassin-delyle","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2022.e09030_bib4","series-title":"Human Physiology from Cells to Systems Ninth Edition","author":"Sherwood","year":"2016"},{"key":"10.1016\/j.heliyon.2022.e09030_bib5","series-title":"Human Physiology an Integrated Approach Edition 6E","author":"Silverthorn","year":"2013"},{"key":"10.1016\/j.heliyon.2022.e09030_bib6","series-title":"Book Review: Pharmacotherapy: A Pathophysiologic Approach","author":"DiPiro","year":"2009"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e09030_bib7","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.33786\/JCPR.2014.v04i03.008","article-title":"Nasal drug delivery: problem solution and its application","volume":"4","author":"NM","year":"2014","journal-title":"J.\u00a0Curr. Pharma. Res."},{"key":"10.1016\/j.heliyon.2022.e09030_bib8","series-title":"Intranasal Drug Delivery : How , Why and what for ?","first-page":"288","volume":"12","author":"Pires","year":"2009"},{"issue":"6","key":"10.1016\/j.heliyon.2022.e09030_bib9","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.autrev.2017.04.008","article-title":"The blood brain barrier and neuropsychiatric lupus: new perspectives in light of advances in understanding the neuroimmune interface","volume":"16","author":"Stock","year":"2017","journal-title":"Autoimmun. Rev."},{"issue":"September 2017","key":"10.1016\/j.heliyon.2022.e09030_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2017.11.047","article-title":"Nanosystems in nose-to-brain drug delivery : a review of non-clinical brain targeting studies","volume":"270","author":"Pires","year":"2018","journal-title":"J.\u00a0Contr. Release"},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2022.e09030_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijpharm.2018.10.029","article-title":"Advanced formulations for intranasal delivery of biologics","volume":"553","author":"Rohrer","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.heliyon.2022.e09030_bib12","series-title":"Polytherapy with Sodium Channel-Blocking Antiepileptic Drugs Is Associated with Arrhythmogenic ST-T Abnormality in Patients with Epilepsy","first-page":"81","volume":"40","author":"Ishizue","year":"2016"},{"key":"10.1016\/j.heliyon.2022.e09030_bib13","series-title":"Probenecid-inhibitable Efflux Transport of Valproic Acid in the Brain Parenchymal Cells of Rabbits : a Microdialysis Study","first-page":"77","volume":"884","author":"Scism","year":"2000"},{"key":"10.1016\/j.heliyon.2022.e09030_bib14","article-title":"Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model","author":"Eskandari","year":"2011","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e09030_bib15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1039\/C5BM00532A","article-title":"Stimuli-responsive dendrimers in drug delivery","volume":"4","author":"Wang","year":"2016","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.heliyon.2022.e09030_bib16","series-title":"Biocompatible Titania Microtubes Formed by Nanoparticles and its Application in the Drug Delivery of Valproic Acid","first-page":"70","volume":"29","author":"Lopez","year":"2006"},{"key":"10.1016\/j.heliyon.2022.e09030_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/jphp.12800","article-title":"Characterisation, in-vitro and in-vivo evaluation of valproic acid-loaded nanoemulsion for improved brain bioavailability","author":"Tan","year":"2017","journal-title":"J.\u00a0Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e09030_bib18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0006-8993(92)91330-H","article-title":"Comparison of anticonvulsant effects of valproic acid entrapped in positively and negatively charged liposomes in amygdaloid-kindled rats","volume":"593","author":"Mori","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.heliyon.2022.e09030_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.heliyon.2022.e09030_bib20","series-title":"Application of Nanotechnology in Drug Delivery","article-title":"Liposomes as potential drug carrier systems for drug delivery","author":"\u00c7a\u011fda\u015f","year":"2014"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e09030_bib21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","article-title":"DDSolver: an add-in program for modeling and comparison of drug dissolution profiles","volume":"12","author":"Zhang","year":"2010","journal-title":"AAPS J."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e09030_bib23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s40005-015-0190-3","article-title":"Development of phenytoin intranasal microemulsion for treatment of epilepsy","volume":"45","author":"Acharya","year":"2015","journal-title":"J.\u00a0Pharm. Investig."},{"key":"10.1016\/j.heliyon.2022.e09030_bib24","series-title":"A\u00a0Study of Rivastigmine Liposomes for Delivery into the Brain through Intranasal Route","first-page":"287","volume":"58","author":"Arumugam","year":"2008"},{"key":"10.1016\/j.heliyon.2022.e09030_bib25","article-title":"Amelioration of ischaemia reperfusion-induced cerebral injury in mice by liposomes containing Allium cepa fraction administered intranasally. Artif Cells","author":"Singh","year":"2018","journal-title":"Nanomed. Biotechnol."},{"key":"10.1016\/j.heliyon.2022.e09030_bib26","series-title":"Handbook of Pharmaceutical Excipients","author":"Rowe","year":"2009"},{"key":"10.1016\/j.heliyon.2022.e09030_bib27","first-page":"1","article-title":"Hazardous chemicals handbook","author":"Carson","year":"2013","journal-title":"Hazard Chem. Handb."},{"key":"10.1016\/j.heliyon.2022.e09030_bib28","article-title":"A\u00a0basic guide to particle characterization","year":"2012","journal-title":"Inf. White Pap."},{"key":"10.1016\/j.heliyon.2022.e09030_bib29","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2014.0459","article-title":"Liposomes in tissue engineering and regenerative medicine","author":"Monteiro","year":"2014","journal-title":"J.\u00a0R. Soc. Interface"},{"key":"10.1016\/j.heliyon.2022.e09030_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2016.04.002","article-title":"Lipid based noninvasive vesicular formulation of cytarabine: nanodeformable liposomes","author":"Raj","year":"2016","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e09030_bib31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2017018693","article-title":"Lipid nanoparticles for nasal\/intranasal drug delivery","volume":"34","author":"Cunha","year":"2017","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.heliyon.2022.e09030_bib32","series-title":"Smart Polymers in Nasal Drug Delivery","author":"Chonkar","year":"2015"},{"key":"10.1016\/j.heliyon.2022.e09030_bib33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.lfs.2016.08.033","article-title":"Development of risperidone liposomes for brain targeting through intranasal route","volume":"163","author":"Narayan","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2022.e09030_bib34","article-title":"Preliminary studies on brain targeting of intranasal atomoxetine liposomes","author":"Vaidya","year":"2016","journal-title":"Int. J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.heliyon.2022.e09030_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2011.11.010","article-title":"Modern methods for delivery of drugs across the blood-brain barrier","author":"Chen","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.heliyon.2022.e09030_bib36","doi-asserted-by":"crossref","DOI":"10.14227\/DT040497P23","article-title":"FDA guidance for industry extended release solid oral dosage forms: development, evaluation, and application of in vitro\/in vivo correlations","author":"Malinowski","year":"1997","journal-title":"Dissolution Technol."},{"issue":"10","key":"10.1016\/j.heliyon.2022.e09030_bib37","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1055\/a-0596-7288","article-title":"Quantification and brain targeting of eugenol-loaded surface modified nanoparticles through intranasal route in the treatment of cerebral Ischemia","volume":"68","author":"Ahmad","year":"2018","journal-title":"Drug Res."},{"key":"10.1016\/j.heliyon.2022.e09030_bib38","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.foodres.2018.03.048","article-title":"Pluronics modified liposomes for curcumin encapsulation: sustained release, stability and bioaccessibility","volume":"108","author":"Ling","year":"2018","journal-title":"Food Res. Int."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e09030_bib39","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijpharm.2017.09.059","article-title":"Preparation of mixed monoterpenes edge activated PEGylated transfersomes to improve the in vivo transdermal delivery efficiency of sinomenine hydrochloride","volume":"533","author":"Wang","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.heliyon.2022.e09030_bib40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejpb.2017.10.008","article-title":"In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin","volume":"122","author":"Mura","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"January","key":"10.1016\/j.heliyon.2022.e09030_bib41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijpharm.2019.02.026","article-title":"How to characterize a nasal product. The state of the art of in vitro and ex vivo specific methods","volume":"561","author":"Salade","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2022.e09030_bib42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijpharm.2017.12.047","article-title":"Stability, biocompatibility and antioxidant activity of PEG-modified liposomes containing resveratrol","volume":"538","author":"Caddeo","year":"2018","journal-title":"Int. J. Pharm."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022003188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022003188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T11:03:38Z","timestamp":1762513418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844022003188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2405844022003188"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09030","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study of valproic acid liposomes for delivery into the brain through an intranasal route","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e09030"}}